Salem Radio Network News Tuesday, January 19, 2021


Sanofi, Glaxo advance talks to supply up to 300 million COVID-19 vaccine does to Europe: companies

(Reuters) – Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses of the drugmakers’s experimental COVID-19 vaccine.

The doses would be manufactured in European countries including France, Belgium, Germany and Italy.

Sanofi is leading the clinical development of the vaccine and expects to launch a pivotal trial by the end of this year.

(Reporting By Deena Beasley; editing by Grant McCool)


Editorial Cartoons

View More »

Michael Ramirez
Thu, Jan 14, 2021